The (Poly)Pharmacology of Cannabidiol in Neurological and Neuropsychiatric Disorders: Molecular Mechanisms and Targets.

Vitale, Rosa Maria; Iannotti, Fabio Arturo; Amodeo, Pietro

Vitale, Rosa Maria; Iannotti, Fabio Arturo; Amodeo, Pietro.

Afiliación

Vitale RM; Institute of Biomolecular Chemistry, National Research Council (ICB-CNR), Via Campi Flegrei 34, 80078 Pozzuoli, NA, Italy.
Iannotti FA; Institute of Biomolecular Chemistry, National Research Council (ICB-CNR), Via Campi Flegrei 34, 80078 Pozzuoli, NA, Italy.
Amodeo P; Endocannabinoid Research Group (ERG), Institute of Biomolecular Chemistry, National Research Council (ICB-CNR), Via Campi Flegrei 34, 80078 Pozzuoli, NA, Italy.

Int J Mol Sci ; 22(9)2021 May 05.

Article en En | MEDLINE | ID: mdl-34062987

Asunto(s)

Cannabidiol/uso terapéutico; Trastornos Mentales/tratamiento farmacológico; Trastornos Mentales/genética; Terapia Molecular Dirigida; Animales; Cannabidiol/química; Cannabidiol/farmacología; Humanos; Canales Iónicos/metabolismo; Modelos Moleculares

Palabras clave

cannabidiol; neuropsychiatric disorders; pharmacological targets; pharmacology; receptors

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Cannabidiol / Terapia Molecular Dirigida / Trastornos Mentales Tipo de estudio: Diagnostic_studies Idioma: En Revista: Int J Mol Sci Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google